Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine

British Journal of Clinical Pharmacology
J C Roos

Abstract

1 The cardiovascular effects of the tricyclic antidepressants (TCAs) are reviewed and compared with those of fluvoxamine, a new 5-hydroxytryptamine (5-HT) re-uptake inhibitor. 2 The TCAs have important effects on the heart, related to their anticholinergic and quinidine-like properties. The major side effects in therapeutic dosage include heart rate increase, postural hypotension and slight prolongation of the intraventricular conduction time and QT interval. In toxic dosage (or normal dosage in patients with severe heart disease) both advanced heart block and ventricular arrhythmias can occur, together with clinically important loss of myocardial contractile force. 3 Fluvoxamine has no effects on the heart except for a statistically (but not clinically) significant slowing of the heart rate.

References

Aug 1, 1977·British Journal of Pharmacology·V ClaassenP Placheta
Feb 1, 1975·Australian and New Zealand Journal of Medicine·J VohraG Sloman
Sep 16, 1972·Lancet·D C MoirR D Weir
Mar 3, 1973·British Medical Journal·R H BriantC T Dollery
Jun 1, 1974·Acta Medica Scandinavica·C Thorstrand
Feb 10, 1973·British Medical Journal·A J BoakesB N Prichard
Aug 31, 1970·JAMA : the Journal of the American Medical Association·J F MeyerL I Goldberg
Mar 1, 1971·Annals of Internal Medicine·R B Williams, C Sherter
Jan 1, 1969·Circulation·B J ScherlagA N Damato
Sep 1, 1969·Toxicology and Applied Pharmacology·A R Laddu, P Somani
Jul 1, 1981·Acta Psychiatrica Scandinavica·C J KlokD Doogan
Sep 1, 1982·Journal of Affective Disorders·J E De Wilde, D P Doogan
Jan 1, 1983·British Journal of Clinical Pharmacology·J D GuelfiP Pichot
Jan 1, 1983·British Journal of Clinical Pharmacology·J E De WildeJ S Wakelin
Dec 1, 1982·British Journal of Clinical Pharmacology·J F Robinson, D P Doogan
Jun 1, 1980·Clinical Pharmacology and Therapeutics·R C VeithR Bielski
May 1, 1961·Clinical Pharmacology and Therapeutics·O F MULLERS BELLET
Jan 1, 1961·Acta Psychiatrica Scandinavica·E S Kristiansen

❮ Previous
Next ❯

Citations

Jan 1, 1991·European Journal of Clinical Pharmacology·C StrömbergM Kupari
Jan 1, 1988·European Journal of Clinical Pharmacology·C StrömbergT Seppälä
Jan 1, 1995·European Archives of Psychiatry and Clinical Neuroscience·W HewerW F Gattaz
Jan 1, 1994·European Archives of Psychiatry and Clinical Neuroscience·F HohagenM Berger
Jul 26, 2008·Current Psychiatry Reports·Rajnish MagoMichael E Thase
Jan 1, 1992·Journal of Psychosomatic Research·H G Series
Apr 1, 1995·International Journal of Cardiology·M ApplebyB Clarke
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·D RothD V Sheehan
Jun 22, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Abbas PoustiAzam Bakhtiarian
Jun 21, 1986·Lancet·J A Henry, S L Cassidy
Apr 8, 1999·Journal of the American College of Cardiology·J FeenstraB H Stricker
Jan 1, 1989·Psychological Medicine. Monograph Supplement·S J WarringtonM Lader
Nov 1, 1987·Medical Toxicology and Adverse Drug Experience·J A Henry, A J Martin
Jan 7, 2015·The Journal of Toxicological Sciences·Yukiko Yamazaki-HashimotoAtsushi Sugiyama
Dec 7, 2006·Journal of the American Academy of Dermatology·Dorota KrasowskaWojciech Myśliński
Jul 4, 2003·British Journal of Pharmacology·James T MilnesHarry J Witchel
Mar 18, 2010·British Journal of Clinical Pharmacology·Guillaume MontastrucUNKNOWN French Association of Regional PharmacoVigilance Centres
Jan 1, 1987·Journal of Clinical Pharmacology·C M Lathers, L J Lipka
May 9, 2002·Expert Opinion on Pharmacotherapy·Paul J GoodnickFrancisco Parra
Oct 6, 2000·Acta Psychiatrica Scandinavica. Supplementum·S PerettiI Hindmarch
Apr 1, 1994·The International Journal of Eating Disorders·J L Ayuso-GutierrezJ L Ayuso-Mateos
Nov 29, 2016·Basic & Clinical Pharmacology & Toxicology·Chiara FabbriAlessandro Serretti
Jun 21, 2013·Journal of Psychopharmacology·Eromona Whiskey, David Taylor
Feb 19, 2003·Human Psychopharmacology·Abbas PoustiBijan Naghibi
Oct 3, 1999·Journal of Clinical Psychopharmacology·S L RasmussenP Tanghøj
Jun 25, 1988·British Medical Journal·G J Huston
Jun 25, 1988·British Medical Journal·A K Banerjee
Aug 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·A K Banerjee
Feb 1, 1993·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·I AhmedR I Shader
Jun 27, 1992·BMJ : British Medical Journal·J G Edwards
Feb 2, 2019·International Journal of Psychiatry in Clinical Practice·Siegfried Kasper
Mar 3, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Rudolf A WernerTakahiro Higuchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.